The class of anxiety drugs called benzodiazepines interact with buprenorphine to cause dangerous effects, but the risks might be worth it to keep people in treatment for opioid use disorder.
Jan. 22

In an effort to reduce harmful interactions and overdoses, providers may be going too far in steering people with opioid use disorder away from anxiety medication, a new study suggests.

Marketing that targets physicians may sway prescribing behavior and contribute to the oversupply of stimulants.
Jan. 21

Amid widespread prescription stimulant misuse, new research begins to characterize how pharmaceutical marketing may play a role.

Jan. 9

Being uninsured or enrolled in Medicaid is a major factor in the stage of cancer at diagnosis, a new study finds.